Among Japanese patients with de novo metastatic prostate cancer, LDH and C-reactive protein (CRP) have been reported as independent risk factors for OS in analyses identifying true high-risk groups that meet the CHAARTED or LATITUDE criteria23. Here, CRP is linked to metastatic prostate carcinoma.